Success Stories: Our Adept Team Helped a Postdoctoral Research Associate to Obtain NIW approval in the Field of Biomedical Science, Without an RFE

 

Client’s Testimonial:

“Thank you so much!”


On February 16nd, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Post-Doctoral Research Associate in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: Taiwan

State of Residence at the Time of Filing: New York

Approval Notice Date: February 16nd, 2021

Processing Time: 7 months, 21 days


Case Summary:

North America Immigration Law Group was contacted by a post-doctoral research associate from Taiwan with a Ph.D. in nutrition science to assist her in filing an I-140 NIW (National Interest Waiver) petition on her behalf. Based on her scholastic background, experience, the record of publication and citation, and the history of her successful research in the field of biomedical science made her an excellent candidate to achieve NIW approval. Without any doubt, we started forming a strong case for her.

To assure that our client is an irreproachable resource to continue her work in the United States, we explained her research on the underlying mechanisms and key molecular and gene regulators of the liver and small intestine to identify therapeutic targets and improve the treatment of gastrointestinal and metabolic diseases. Also, we deduced that her research is of great importance because it has improved the field’s comprehensive understanding of metabolic and gastrointestinal diseases, thus paving the way for improved treatments.

Also, we noted the 161 citations accumulated from the 11 peer-reviewed journal articles (6 of them first-authored and 1 co-first-authored), 1 first-authored commentary, and 1 first-authored preprint article she published, indicating her work benefitting her peers in the field. Moreover, we stated that she had published papers in no fewer than 5 highly ranked or impactful peer-reviewed journals.

We attached four recommendation letters obtained from her fellow renowned experts in the field, indicating her work’s extraordinary impact on the field, and one of her recommenders worded:

“In order to support the continued success of the U.S. pharmaceutical industry and maintain the nation’s competitive international edge, we require researchers like [client], whose work is further applicable to the development of new therapeutics and drugs for diseases… Her unique expertise and established authority in the field have been critical to its advancement, and thus, her ongoing research is essential.”

The USCIS adjudicated her case thoroughly and was successfully persuaded to approve her petition without an RFE (request for evidence). We congratulate her on achieving the NIW approval and advancing in her area in the United States.